CrossFit in Enhancing Movement and Quality of Life in Cancer Survivors and Caregivers
This trial studies how high-intensity interval training (CrossFit) enhances movement and quality of life in cancer survivors and caregivers. It is recommended that cancer survivors avoid inactivity and return to normal activity as soon as possible following their diagnosis, including strength training. CrossFit is a type of high-intensity interval training program that focuses on strength and skill building. It is not yet known if CrossFit will enhance movement and quality of life in cancer survivors and caregivers.
Inclusion Criteria
- CANCER SURVIVOR PILOT INTERVENTION: Aged 18 and older at the time of program recruitment
- CANCER SURVIVOR PILOT INTERVENTION: Diagnosed with an invasive cancer
- CANCER SURVIVOR PILOT INTERVENTION: Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist) * Former CAPABLE participants do not require repeated clearance from physician
- CANCER SURVIVOR PILOT INTERVENTION: Available transportation to and from the facility on session days
- PRIMARY CAREGIVER PILOT INTERVENTION: Age 18 and older at the time of program recruitment
- PRIMARY CAREGIVER PILOT INTERVENTION: Identified by a cancer survivor as the primary caregiver for a cancer patient diagnosed on or after 1/1/2017
- PRIMARY CAREGIVER PILOT INTERVENTION: Cleared from their primary care physician to participate in the program
- PRIMARY CAREGIVER PILOT INTERVENTION: Available transportation to and from the facility on session days
- CANCER SURVIVOR P30 SUBGROUP: Aged 18 and older at the time of program recruitment
- CANCER SURVIVOR P30 SUBGROUP: Diagnosed with an invasive cancer within 4 years of the screening date
- CANCER SURVIVOR P30 SUBGROUP: Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist) * Former CAPABLE participants do not require repeated clearance from physician, unless their health history has changed
- CANCER SURVIVOR P30 SUBGROUP: Not currently participating in regular physical activity (150 mins or less per week)
- CANCER SURVIVOR P30 SUBGROUP: 50%+ of participants for this sub-group must identify as African-American or Black
- Strategic Research Initiative Grant (SRIG) SUBGROUP: Aged 18 and older at the time of program recruitment
- SRIG SUBGROUP: Self-identifying as Arab-American or part of the Arab/ Arab-American community
- SRIG SUBGROUP: Self-identifying as female
- SRIG SUBGROUP: Diagnosed with an invasive cancer -OR- high risk for developing cancer in the future as outlined below * Body mass index that is obese (based on height/weight calculation) * Age 40 or older * Family history of cancer (Both cancer survivors and community members never diagnosed with cancer may enroll)
- SRIG SUBGROUP: Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist)
- SRIG SUBGROUP: Not currently participating in regular physical activity (150 mins or less per week)
Exclusion Criteria
- CANCER SURVIVOR PILOT INTERVENTION: Widely metastatic cancers. However, bone metastatic cancers that are in remission and newly diagnosed metastatic cancers will be acceptable with physician approval
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03750981.
Locations matching your search criteria
United States
Michigan
Detroit
PRIMARY OBJECTIVES
I. To estimate enrollment rates among those who respond to notices about the study and adherence to the program among those who enroll.
II. Describe reported barriers to participation among respondents who do not ultimately enroll.
III. Estimate adherence improvement due to enrolling as a dyad with a primary caregiver.
IV. To estimate measures of functional performance and variability in functional performance among adult cancer survivors and primary caregivers enrolled in a high-intensity functional training program at baseline at regular intervals during the study and at the conclusion of the program..
V. To estimate self-reported health-related quality of life (HRQOL) and variability using the Functional Assessment of Cancer Therapy (FACT) questionnaire at baseline, at regular intervals throughout the pilot study and again at the end of the program.
VI. To estimate changes in weight, waist circumference, glucose, glycosylated hemoglobin A1c, lipid levels, body fat percentage, visceral fat, body mass index, resting metabolism and skeletal muscle from baseline at the end of the program.
VII. To assess qualitatively motivation to exercise, barriers to exercise, expectations of the intervention, emotional responses to exercise, motivation to change diet, and satisfaction with the program, starting at baseline and continuing at regular intervals throughout the pilot study until the end of the program.
VIII. Examine the association between sleep quality and duration in relation to physical activity.
OUTLINE:
Participants complete CrossFit sessions 3 times weekly for 12 weeks. Participants also receive the Harvard School of Medicine "Healthy Eating Plate" guide to nutrition on study. Additionally, participants may optionally undergo blood sample collection on study.
Trial PhaseNo phase specified
Trial Typetreatment
Lead OrganizationWayne State University/Karmanos Cancer Institute
Principal InvestigatorJennifer Beebe-Dimmer
- Primary ID2018-091
- Secondary IDsNCI-2018-02625
- ClinicalTrials.gov IDNCT03750981